Dr. Emily Simons joined the Kid Risk team to explore globally-coordinated investments in measles and rubella management and to focus specifically on characterization of the health and economic impacts of rubella. Prior to joining Kid Risk, Dr. Simons worked for over three years at the World Health Organization in Geneva, Switzerland on the analysis of immunization coverage and surveillance data on measles and rubella and on estimating the global burden of measles. Her published research includes papers on the cost-effectiveness of measles vaccination and the use of data for planning vaccination activities. Dr. Simons received her Master of Public Health degree from the Johns Hopkins School of Public Health in 2008, and she received her M.D. from Harvard Medical School in 2016 before joining the Boston Children's Hospital as a Research Fellow.